Dr Michael Vajdy | Co Founder, President and Chief Scientific Officer
Epito Genesis Inc

Dr. Vajdy is Co-founder, Principal and Chief Scientific Officer of EpitoGenesis, Inc., established in 2008. Dr. Vajdy is a mucosal immunologist and Vaccinologist with over 25 years of direct academic and industry experience in designing mucosal and systemic adjuvants and vaccines, studying mucosal and systemic B and T cell immune induction mechanisms and long-term immunological memory, and product development. Following his Ph.D. Studentship at Goteborg University under the supervision of Dr. Nils Lycke, a prominent mucosal immunologist, Dr. Vajdy completed post doctoral fellowships with Dr. Katherine Knight, then President of the American Association of Immunology and Dr. Marian Neutra, a renowned expert in mucosal biology and mucosal HIV vaccine development. He Dr. Vajdy was recruited to Chiron Corporation (later Novartis Vaccines and Diagnostics, Inc.) and remained there for 9.5 years with increasing responsibilities including project leadership for a vaccine manufacturing platform technology. He also held simultaneous academic positions as Adjunct Clinical Assistant Professor with the Department of Internal Medicine, Division of Infectious Diseases and Visiting Associate Professor at Department of Medical Microbiology and Immunology, University of California, Davis. He was also a Faculty member with the graduate group, Department of Comparative Pathology, University of California, Davis. Most recently, Dr. Vajdy was Full Adjunct Professor at Department of Pathobiology, University of Connecticut. In these capacities, he trained students/fellows/interns and wrote collaborative NIH grants. Dr. Vajdy has authored over 54 peer reviewed manuscripts and book chapters; he is the editor of a book entitled “Immunity against Mucosal Pathogens” (Springer, 2008) and has been PI or Investigator on several funded NIH grants.